Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp

[cafead]

via Less than a year ago, Sanofi's CEO Paul Hudson unveiled the company's new “play to win” strategy that centers the company on growth drivers such as Dupixent and vaccines. And that strategy delivered in the third quarter as Dupixent posted blockbuster sales and flu vaccines set a revenue record.

article source